The pathogenesis of rheumatoid arthritis

S Alivernini, GS Firestein, IB McInnes - Immunity, 2022 - cell.com
Significant recent progress in understanding rheumatoid arthritis (RA) pathogenesis has led
to improved treatment and quality of life. The introduction of targeted-biologic and-synthetic …

Critical role of synovial tissue–resident macrophage and fibroblast subsets in the persistence of joint inflammation

S Kemble, AP Croft - Frontiers in immunology, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is a chronic prototypic immune-mediated inflammatory disease
which is characterized by persistent synovial inflammation, leading to progressive joint …

Entinostat neutralizes myeloid-derived suppressor cells and enhances the antitumor effect of PD-1 inhibition in murine models of lung and renal cell carcinoma

A Orillion, A Hashimoto, N Damayanti… - Clinical cancer …, 2017 - aacrjournals.org
Purpose: Recent advances in immunotherapy highlight the antitumor effects of immune
checkpoint inhibition despite a relatively limited subset of patients receiving clinical benefit …

HDAC inhibitors as epigenetic regulators of the immune system: impacts on cancer therapy and inflammatory diseases

EE Hull, MKR Montgomery… - BioMed research …, 2016 - Wiley Online Library
Histone deacetylase (HDAC) inhibitors are powerful epigenetic regulators that have
enormous therapeutic potential and have pleiotropic effects at the cellular and systemic …

[HTML][HTML] Histone deacetylases and their inhibitors in inflammatory diseases

SY Zhang, LY Zhang, R Wen, N Yang… - Biomedicine & …, 2024 - Elsevier
Despite considerable research efforts, inflammatory diseases remain a heavy burden on
human health, causing significant economic losses annually. Histone deacetylases …

Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes

C Angiolilli, PA Kabala, AM Grabiec… - Annals of the …, 2017 - ard.bmj.com
Objectives Non-selective histone deacetylase (HDAC) inhibitors (HDACi) have
demonstrated anti-inflammatory properties in both in vitro and in vivo models of rheumatoid …

Epigenetic drug discovery: breaking through the immune barrier

DF Tough, PP Tak, A Tarakhovsky… - Nature reviews Drug …, 2016 - nature.com
Immune-mediated diseases are clinically heterogeneous but they share genetic and
pathogenic mechanisms. These diseases may develop from the interplay of genetic factors …

Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity

H Wu, Y Deng, Y Feng, D Long, K Ma, X Wang… - Cellular & molecular …, 2018 - nature.com
B cells have a critical role in the initiation and acceleration of autoimmune diseases,
especially those mediated by autoantibodies. In the peripheral lymphoid system, mature B …

Probiotic Lactobacillus rhamnosus GG prevents alveolar bone loss in a mouse model of experimental periodontitis

SM Gatej, V Marino, R Bright… - Journal of clinical …, 2018 - Wiley Online Library
Aim This study investigated the role of Lactobacillus rhamnosus GG (LGG) on bone loss and
local and systemic inflammation in an in vivo mouse model of experimental periodontitis …

[HTML][HTML] Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: Insights into subsets, markers, and signaling pathways

QY Su, HC Li, XJ Jiang, ZQ Jiang, Y Zhang… - Biomedicine & …, 2024 - Elsevier
Rheumatoid arthritis (RA) is a complex autoimmune inflammatory rheumatic disease
characterized by an imbalance between immunological reactivity and immune tolerance …